Home / Health / Colon Cancer Deaths Decline

Colon Cancer Deaths Decline

Published: Mar 17, 2014 | Updated: Mar 17, 2014

The occurrence of colon cancer in comparison adults decreased by 30% in a final decade, coinciding with a tripling of a colonoscopy rate, the American Cancer Society (ACS) reported.

Overall, a occurrence of a third many common cancer decreased by 3.4% annually from 2001 to 2010. However, a advantage was driven by a 3.9% annualized decrease in people ≥50, that was equivalent to some border by a 1.1% annual boost in younger people. Colon cancer mankind decreased by a identical rate during a same time frame, reported Rebecca Siegel, MPH, and colleagues, all from a ACS in Atlanta.

Much of a credit for a reduce occurrence of colorectal cancer goes to softened uptake of colonoscopy among people ages 50 to 75, that rose from 19% in 2000 to 55% in 2010, they wrote in a March/April emanate ofCA: A Cancer Journal for Clinicians.

“Among adults aged 50 years and older, a rate of decrease has surged, quite among those aged 65 years and older, among whom a annual percent decrease in distal tumors accelerated from 5.2% during 2001 to 2008 to 9.5% during 2008 to 2010,” they said.

“Larger declines among Medicare-eligible seniors expected simulate aloft rates of screening since of concept word coverage,” they added. “In 2010, 55% of adults aged 50 to 64 years reported carrying undergone a new colorectal cancer screening test, compared with 64% of those age 65 years and older.”

The commentary came from an research of information from a National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program, a North American Association of Central Cancer Registries, and the National Center for Health Statistics.

Collectively, a information documented declines in colon cancer occurrence and mankind over a past decade, though also showed that not all segments of a race benefited equally.

From 2006 to 2010, colon cancer occurrence was top in non-Hispanic blacks: 63.8 cases per 100,000 in group and 47.8 per 100,000 in women. Asian/Pacific Islanders had a lowest rates (40.8/100,000 in men, 31/100,000 in women). Overall occurrence during a 5-year duration were 51.7/100,000 in group and 39.1/100,000 in women.

Similar disparities emerged from a research of mortality, that ranged from 29.4/100,000 in black group and 19.4/100,000 in black women to 13.1 and 9.7/100,000 in Asian/Pacific Islander group and women, respectively.

The information also showed substantial movement in growth plcae by age. The suit of proximally located tumors increasing from 27% in group 50 to 49% in people ≥80. A identical age-related settlement was seen in women. Distally located tumors were many common in group 50 to 64 (27%) and women 50 (28%) and slightest common in group and women 80 (20% and 17%, respectively).

Tumors arose many mostly in a rectum among group and women 50 (41% and 37%, respectively) and slightest mostly in group and women 80 (22% and 17%, respectively).

Despite a improving epidemiologic picture, colorectal cancer will sojourn a third many common and third many lethal cancer in a U.S.. During 2014, about 137,000 new cases of colorectal cancer will be diagnosed (71,830 in men, 65,000 in women) and 50,000 people will die of a illness (26,270 men, 24,040 women).

“These stability drops in occurrence and mankind uncover a lifesaving intensity of colon cancer screening, a intensity than an estimated 23 million Americans between ages 50 and 75 are not benefiting from since they are not adult to date on screening,” Richard Wender, MD, ACS arch cancer control officer, pronounced in a statement.

“Sustaining this carefree trend will need petrify efforts to make certain all patients, quite those who are economically disenfranchised, have entrance to screening and to a best caring available,” he stated.

All authors are ACS employees. The authors reported no conflicts of interest.


Primary source: CA: A Cancer Journal for Clinicians
Source reference: Siegel RH, et al. “Colorectal Cancer Statistics, 2014″ CA Cancer J Clin 2014; DOI: 10.3322/caac.21220.

Charles Bankhead

Staff Writer

open bio Working from Houston, home to one of a world’s largest medical complexes, Charles Bankhead has some-more than 20 years of knowledge as a medical author and editor. His career began as a scholarship and medical author during an educational medical center. He after spent roughly a decade as a author and editor for Medical World News, one of a heading medical trade magazines of a era. His byline has seemed in medical publications that have enclosed Cardio, Cosmetic Surgery Times, Dermatology Times, Diagnostic Imaging, Family Practice, Journal of a National Cancer Institute, Medscape, Oncology News International, Oncology Times, Ophthalmology Times, Patient Care, Renal and Urology News, The Medical Post, Urology Times, and a International Medical News Group newspapers. He has a BA in broadcasting and MA in mass communications, both from Texas Tech University.

Article source: http://www.medpagetoday.com/HematologyOncology/ColonCancer/44787

Scroll To Top